What's in Spanish Oncology Genito-Urinary Group's pipeline?

Spanish Oncology Genito-Urinary Group has 3 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Spanish Oncology Genito-Urinary Group's portfolio?

Top competitors by shared drug class: Bayer, Beta Pharma Shanghai, Betta Pharmaceuticals Co., Ltd., Caliway Biopharmaceuticals Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/spanish-oncology-genito-urinary-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Spanish Oncology Genito-Urinary Group — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spanish Oncology Genito-Urinary Group pipeline: 0 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Beta Pharma Shanghai · 1 shared drug class
Betta Pharmaceuticals Co., Ltd. · 1 shared drug class
Caliway Biopharmaceuticals Co., Ltd. · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 shared drug class
Eisai Inc. · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Allist Pharmaceuticals, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Spanish Oncology Genito-Urinary Group:

Cite this brief

Drug Landscape (2026). Spanish Oncology Genito-Urinary Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/spanish-oncology-genito-urinary-group. Accessed 2026-05-16.